Literature DB >> 22851332

The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells.

Chih-Rong Shyr1, Chi-Cheng Chen, Teng-Fu Hsieh, Chao-Hsiang Chang, Wen-Lung Ma, Shuyuan Yeh, Edward Messing, Tsung-Heng Li, Fu-Yin Li, Chawnshang Chang.   

Abstract

Sex hormone receptors, androgen receptor (AR) and estrogen receptors (ERs) including both ERα and ERβ, mediate the actions of sex hormones. In this study, we aimed to evaluate sex hormone receptors expression in upper urinary tract urothelial carcinomas (UUTUCs) of ureter and renal pelvis with different tumor stages and grades as well as their possible roles in tumor progression. Immunohistochemistry was used to assay the expression of AR and ERs in the primary UUTUCs. XTT viability test was applied to evaluate cell responses for anticancer drug treatment. Wound healing assay was performed to determine cell migration abilities. AR and ERβ immunoreactivities were observed in both UUTUCs, but ERα was not detected in either UUTUCs. In UUTUC of ureter specimens, higher AR expression was found in superficial or lower grade tumors. In contrast, little difference of ERβ expression was found in superficial versus muscle-invasive tumor stages or low grades versus high grades in UUTUCs of ureter specimens. Furthermore in the primary cultured cells from UUTUC specimens, the addition of functional AR reduced cell chemosensitivity, but increased cell migration. These results provide the first data showing the expression patterns of sex hormone receptors in both renal pelvis and ureter UUTUCs. From results, we concluded that there is a positive correlation for higher AR expression found in superficial or low-grade UUTUCs of ureter and identified the functional roles of AR in UUTUC progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22851332     DOI: 10.1007/s12020-012-9762-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  34 in total

Review 1.  Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development.

Authors:  Gerald R Cunha; Will Ricke; Axel Thomson; Paul C Marker; Gail Risbridger; Simon W Hayward; Y Z Wang; Annemarie A Donjacour; Takeshi Kurita
Journal:  J Steroid Biochem Mol Biol       Date:  2004-12-21       Impact factor: 4.292

Review 2.  Development and progression of urothelial carcinoma.

Authors:  Tadao Kakizoe
Journal:  Cancer Sci       Date:  2006-07-04       Impact factor: 6.716

3.  Characterization of two urothelium cancer cell lines derived from a blackfoot disease endemic area in Taiwan.

Authors:  C C Tzeng; H S Liu; C Li; Y T Jin; R M Chen; W H Yang; J S Lin
Journal:  Anticancer Res       Date:  1996 Jul-Aug       Impact factor: 2.480

Review 4.  Localization of androgen and estrogen receptors in rat and primate tissues.

Authors:  G Pelletier
Journal:  Histol Histopathol       Date:  2000-10       Impact factor: 2.303

5.  Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.

Authors:  Hiroshi Miyamoto; Jorge L Yao; Alcides Chaux; Yichun Zheng; Iawen Hsu; Koji Izumi; Chawnshang Chang; Edward M Messing; George J Netto; Shuyuan Yeh
Journal:  BJU Int       Date:  2012-01-05       Impact factor: 5.588

6.  Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicin.

Authors:  S P Ackland; M J Ratain; N J Vogelzang; K E Choi; M Ruane; J A Sinkule
Journal:  Clin Pharmacol Ther       Date:  1989-04       Impact factor: 6.875

7.  Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression.

Authors:  Can Tuygun; Duygu Kankaya; Abdurrahim Imamoglu; Ayse Sertcelik; Kursad Zengin; Murat Oktay; Nurettin Sertcelik
Journal:  Urol Oncol       Date:  2009-04-16       Impact factor: 3.498

8.  Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.

Authors:  Stephen Boorjian; Stacy Ugras; Nigel P Mongan; Lorraine J Gudas; Xueke You; Satish K Tickoo; Douglas S Scherr
Journal:  Urology       Date:  2004-08       Impact factor: 2.649

9.  Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.

Authors:  James W F Catto; Abdel-Rahmene Azzouzi; Najla Amira; Ishtiaq Rehman; Kenneth M Feeley; Simon S Cross; Gaelle Fromont; Mathilde Sibony; Freddie C Hamdy; Oliver Cussenot; Mark Meuth
Journal:  Oncogene       Date:  2003-11-27       Impact factor: 9.867

Review 10.  The nuclear receptor superfamily: the second decade.

Authors:  D J Mangelsdorf; C Thummel; M Beato; P Herrlich; G Schütz; K Umesono; B Blumberg; P Kastner; M Mark; P Chambon; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

View more
  17 in total

1.  Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract.

Authors:  Eiji Kashiwagi; Kazutoshi Fujita; Seiji Yamaguchi; Hiroaki Fushimi; Hiroki Ide; Satoshi Inoue; Taichi Mizushima; Leonardo O Reis; Rajni Sharma; George J Netto; Norio Nonomura; Hiroshi Miyamoto
Journal:  Cancer Biol Ther       Date:  2016-09-16       Impact factor: 4.742

2.  Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.

Authors:  G J Wirth; A Haitel; M Moschini; F Soria; T Klatte; M R Hassler; K Bensalah; A Briganti; J A Karam; Y Lotan; V Margulis; J D Raman; M Remzi; N Rioux-Leclercq; B D Robinson; M Rouprêt; C G Wood; S F Shariat
Journal:  World J Urol       Date:  2016-10-11       Impact factor: 4.226

3.  Strict rules are needed for validation of G-protein-coupled receptor immunohistochemical studies in human tissues.

Authors:  Jean Claude Reubi
Journal:  Endocrine       Date:  2014-06-10       Impact factor: 3.633

Review 4.  Gender differences in incidence and outcomes of urothelial and kidney cancer.

Authors:  Ilaria Lucca; Tobias Klatte; Harun Fajkovic; Michela de Martino; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2015-10       Impact factor: 14.432

Review 5.  Role of androgen receptor expression in non-muscle-invasive bladder cancer: a systematic review and meta-analysis.

Authors:  Francesca Sanguedolce; Luigi Cormio; Giuseppe Carrieri; Beppe Calò; Davide Russo; Andrea Menin; Antonio Luigi Pastore; Francesco Greco; Giorgio Bozzini; Antonio Galfano; Giovannalberto Pini; Angelo Porreca; Filippo Mugavero; Mario Falsaperla; Carlo Ceruti; Luca Cindolo; Alessandro Antonelli; Andrea Minervini
Journal:  Histol Histopathol       Date:  2019-12-05       Impact factor: 2.303

6.  Androgen receptor facilitates the recruitment of macrophages in tumor microenvironment to promote upper urinary tract urothelial cell carcinoma progression.

Authors:  Chi-Cheng Chen; Chi-Ping Huang; Teng-Fu Hsieh; Wei-Kai Chiu; Wen-Ling Chang; Chih-Rong Shyr
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

7.  Androgen receptor expands the population of cancer stem cells in upper urinary tract urothelial cell carcinoma cells.

Authors:  Chi-Cheng Chen; Teng-Fu Hsieh; Chi-Ping Huang; Ai-Lin Yu; Wen-Lin Chang; Chih-Rong Shyr
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

8.  Androgen receptor immunohistochemistry in genitourinary neoplasms.

Authors:  Elizabeth M Williams; John P Higgins; Ankur R Sangoi; Jesse K McKenney; Megan L Troxell
Journal:  Int Urol Nephrol       Date:  2014-09-14       Impact factor: 2.370

9.  Expression of DBC1 and Androgen Receptor Predict Poor Prognosis in Diffuse Large B Cell Lymphoma.

Authors:  Ho Sung Park; Jun Sang Bae; Sang Jae Noh; Kyung Min Kim; Ho Lee; Woo Sung Moon; Myoung Ja Chung; Myoung Jae Kang; Dong Geun Lee; Kyu Yun Jang
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

10.  Androgen receptor decreases the cytotoxic effects of chemotherapeutic drugs in upper urinary tract urothelial carcinoma cells.

Authors:  Teng-Fu Hsieh; Chi-Cheng Chen; Ai-Lin Yu; Wen-Lung Ma; Caixia Zhang; Chih-Rong Shyr; Chawnshang Chang
Journal:  Oncol Lett       Date:  2013-01-18       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.